NEWPHARMA GROUP

{
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-11-20",
    "filing_date": "2025-11-12",
    "act_kind_objet": "OP\u00C9RATION ASSIMIL\u00C9E \u00C0 LA FUSION PAR ABSORPTION DE \u003C\u003C\u003C SMARTVALUE \u00BB SA - PROC\u00C8S-VERBAL DE L\u0027ASSEMBL\u00C9E G\u00C9N\u00C9RALE EXTRAORDINAIRE DE LA SOCI\u00C9T\u00C9 ABSORBANTE - SUPPRESSION DES CLASSES D\u0027ACTIONS ET ANNULATION DES DROITS DE SOUSCRIPTION DE PARTS B\u00C9N\u00C9FICIAIRES - ADOPTION D\u0027UN NOUVEAU TEXTE DES STATUTS"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-10-28",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "full_restatement",
      "object_change",
      "duration_change",
      "share_class_creation",
      "language_switch",
      "board_authorized_capital",
      "governance_restructure",
      "liquidation_preference_introduction"
    ],
    "scope": "full_restatement",
    "trigger": "wvv_adaptation",
    "language_after": "nl",
    "language_before": "fr"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full_after": "Newpharma Group",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "Newpharma Group",
    "current_zetel_raw": "4020 Li\u00E8ge, Rue du Charbonnage 10 bo\u00EEte 2",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "Colruyt Group",
      "scope_categories": [
        "kbo",
        "ubo",
        "btw"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [
    {
      "summary": "La soci\u00E9t\u00E9 est confirm\u00E9e comme une soci\u00E9t\u00E9 anonyme nomm\u00E9e Newpharma Group.",
      "new_text": "La soci\u00E9t\u00E9 rev\u00EAt la forme d\u0027une soci\u00E9t\u00E9 anonyme. Elle est d\u00E9nomm\u00E9e \u003C\u003C Newpharma Group ",
      "change_kind": "restated",
      "article_title": "FORME JURIDIQUE - D\u00C9NOMINATION",
      "article_number": "1"
    },
    {
      "summary": "Le si\u00E8ge social est \u00E9tabli en R\u00E9gion wallonne et la soci\u00E9t\u00E9 peut \u00E9tablir des si\u00E8ges administratifs ou d\u0027exploitation en Belgique ou \u00E0 l\u0027\u00E9tranger.",
      "new_text": "Le si\u00E8ge de la soci\u00E9t\u00E9 est \u00E9tabli en R\u00E9gion wallonne La soci\u00E9t\u00E9 peut \u00E9tablir, par d\u00E9cision de l\u0027organe d\u0027administration, des si\u00E8ges administratifs, des si\u00E8ges",
      "change_kind": "restated",
      "article_title": "SI\u00C8GE",
      "article_number": "2"
    },
    {
      "summary": "L\u0027objet social a \u00E9t\u00E9 consid\u00E9rablement \u00E9largi pour inclure l\u0027acquisition d\u0027int\u00E9r\u00EAts dans des soci\u00E9t\u00E9s, la gestion de ces int\u00E9r\u00EAts, la fourniture de conseils, l\u0027achat et la vente de biens immobiliers et mobiliers, le commerce de produits pharmaceutiques, la production et commercialisation de technolog",
      "new_text": "La soci\u00E9t\u00E9 a pour objet, tant en Belgique qu\u0027\u00E0 l\u0027\u00E9tranger, tant en son propre nom et pour son propre compte qu\u0027au nom ou pour le compte de tiers, seule ou en coop\u00E9ration avec des tiers: 1. l\u0027acquisition par voie de souscription, achat, contribution, fusion, coop\u00E9ration, intervention financi\u00E8re ou autre, d\u0027un int\u00E9r\u00EAt ou d\u0027une participation dans toutes soci\u00E9t\u00E9s, entreprises, activit\u00E9s, institutions ",
      "change_kind": "restated",
      "article_title": "OBJET",
      "article_number": "3"
    },
    {
      "summary": "La soci\u00E9t\u00E9 existe pour une dur\u00E9e illimit\u00E9e.",
      "new_text": "La soci\u00E9t\u00E9 existe pour une dur\u00E9e illimit\u00E9e",
      "change_kind": "restated",
      "article_title": "DUR\u00C9E",
      "article_number": "4"
    },
    {
      "summary": "Le capital est fix\u00E9 \u00E0 86.745.274,00 euros, repr\u00E9sent\u00E9 par 67.500 actions sans mention de valeur nominale.",
      "new_text": "Le capital est fix\u00E9 \u00E0 quatre-vingt-six millions sept cent quarante-cinq mille deux cent septante-quatre euros (\u20AC 86.745.274,00). Il est repr\u00E9sent\u00E9 par soixante-sept mille cing cents (67.500) actions, sans mention de valeur nominale, repr\u00E9sentant chacune une part \u00E9gale du capital.",
      "change_kind": "restated",
      "article_title": "CAPITAL",
      "article_number": "5"
    },
    {
      "summary": "La soci\u00E9t\u00E9 est administr\u00E9e par un organe d\u0027administration coll\u00E9gial, le conseil d\u0027administration, compos\u00E9 de trois membres minimum. En cas de moins de trois actionnaires, il peut \u00EAtre constitu\u00E9 de deux administrateurs.",
      "new_text": "La soci\u00E9t\u00E9 est administr\u00E9e par un organe d\u0027administration coll\u00E9gial, appel\u00E9 le conseil d\u0027administration, qui est compos\u00E9 de trois membres au moins, personnes physiques ou morales, actionnaires ou non. Tant que la soci\u00E9t\u00E9 compte moins de trois actionnaires, le conseil d\u0027administration peut \u00EAtre constitu\u00E9 de deux administrateurs.",
      "change_kind": "restated",
      "article_title": "COMPOSITION DE L\u0027ORGANE D\u0027ADMINISTRATION",
      "article_number": "8"
    },
    {
      "summary": "L\u0027organe d\u0027administration a les pouvoirs les plus \u00E9tendus pour accomplir tous les actes n\u00E9cessaires ou utiles \u00E0 la r\u00E9alisation de l\u0027objet de la soci\u00E9t\u00E9, \u00E0 l\u0027exception de ceux que la loi r\u00E9serve \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale. Il peut d\u00E9l\u00E9guer la gestion journali\u00E8re \u00E0 une ou plusieurs personnes.",
      "new_text": "L\u0027organe d\u0027administration est investi des pouvoirs les plus \u00E9tendus pour accomplir tous les actes n\u00E9cessaires ou utiles \u00E0 la r\u00E9alisation de l\u0027objet de la soci\u00E9t\u00E9, \u00E0 l\u0027exception de ceux que la loi r\u00E9serve \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale. L\u0027organe d\u0027administration peut d\u00E9l\u00E9guer la gestion journali\u00E8re de la soci\u00E9t\u00E9 \u00E0 une ou plusieurs personnes, personnes physiques ou morales, actionnaires ou non. Lorsqu\u0027un ad",
      "change_kind": "restated",
      "article_title": "POUVOIR DE GESTION - GESTION JOURNALI\u00C8RE",
      "article_number": "10"
    },
    {
      "summary": "L\u0027organe d\u0027administration repr\u00E9sente la soci\u00E9t\u00E9 \u00E0 l\u0027\u00E9gard des tiers et en justice. La soci\u00E9t\u00E9 est \u00E9galement valablement repr\u00E9sent\u00E9e par deux administrateurs agissant conjointement.",
      "new_text": "L\u0027organe d\u0027administration repr\u00E9sente la soci\u00E9t\u00E9 \u00E0 l\u0027\u00E9gard des tiers et en justice, en tant que demandeur ou d\u00E9fendeur. La soci\u00E9t\u00E9 est \u00E9galement valablement repr\u00E9sent\u00E9e \u00E0 l\u0027\u00E9gard des tiers et en justice, en tant que demandeur ou d\u00E9fendeur, par deux administrateurs agissant conjointement.",
      "change_kind": "restated",
      "article_title": "POUVOIR DE REPR\u00C9SENTATION",
      "article_number": "11"
    },
    {
      "summary": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire se r\u00E9unit le troisi\u00E8me mardi du mois de septembre \u00E0 14h30. Une assembl\u00E9e g\u00E9n\u00E9rale sp\u00E9ciale ou extraordinaire peut \u00EAtre convoqu\u00E9e chaque fois que l\u0027int\u00E9r\u00EAt de la soci\u00E9t\u00E9 l\u0027exige.",
      "new_text": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire se r\u00E9unit le troisi\u00E8me mardi du mois de septembre \u00E0 14.30 heures. Si ce jour est un jour f\u00E9ri\u00E9, l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire a lieu le jour ouvrable suivant. Une assembl\u00E9e g\u00E9n\u00E9rale sp\u00E9ciale ou extraordinaire peut \u00EAtre convoqu\u00E9e chaque fois que l\u0027int\u00E9r\u00EAt de la soci\u00E9t\u00E9 l\u0027exige.",
      "change_kind": "restated",
      "article_title": "DATE ASSEMBL\u00C9E G\u00C9N\u00C9RALE ORDINAIRE - ASSEMBL\u00C9E G\u00C9N\u00C9RALE SP\u00C9CIALE/EXTRAORDINAIRE",
      "article_number": "13"
    },
    {
      "summary": "Pour \u00EAtre admis \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale, les d\u00E9tenteurs de titres doivent, si la convocation l\u0027exige, d\u00E9poser leurs titres au moins trois jours ouvrables avant la date fix\u00E9e pour l\u0027assembl\u00E9e.",
      "new_text": "Pour \u00EAtre admis \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale, les d\u00E9tenteurs de titres, qui ont le droit d\u0027\u00EAtre convoqu\u00E9s conform\u00E9ment aux dispositions l\u00E9gales applicables, doivent, si la convocation l\u0027exige, au moins trois jours ouvrables avant la date fix\u00E9e pour l\u0027assembl\u00E9e, d\u00E9poser leurs (certificats de) titres, au si\u00E8ge ou aupr\u00E8s des \u00E9tablissements d\u00E9sign\u00E9s dans les avis de convocation.",
      "change_kind": "restated",
      "article_title": "ADMISSION \u00C0 L\u0027ASSEMBL\u00C9E G\u00C9N\u00C9RALE",
      "article_number": "16"
    },
    {
      "summary": "Tout actionnaire peut se faire repr\u00E9senter \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale par un mandataire. Les procurations doivent \u00EAtre communiqu\u00E9es par \u00E9crit, par lettre, par e-mail ou par tout autre moyen mentionn\u00E9 \u00E0 l\u0027article 1.5 du Code civil et sont d\u00E9pos\u00E9es sur le bureau de l\u0027assembl\u00E9e.",
      "new_text": "Tout actionnaire peut se faire repr\u00E9senter \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale par un mandataire, actionnaire ou non. Les procurations doivent comporter une signature. Les procurations doivent \u00EAtre communiqu\u00E9es par \u00E9crit, par lettre, par e-mail ou par tout autre moyen mentionn\u00E9 \u00E0 l\u0027article 1.5 du Code civil et sont d\u00E9pos\u00E9es sur le bureau de l\u0027assembl\u00E9e. En outre, l\u0027organe d\u0027administration peut exiger que celle",
      "change_kind": "restated",
      "article_title": "REPR\u00C9SENTATION",
      "article_number": "17"
    },
    {
      "summary": "Chaque action donne droit \u00E0 une voix. Chaque actionnaire peut \u00E9galement voter au moyen d\u0027une lettre ou de mani\u00E8re \u00E9lectronique par l\u0027interm\u00E9diaire d\u0027un formulaire \u00E9tabli par l\u0027organe d\u0027administration.",
      "new_text": "Chaque action donne droit \u00E0 une voix. Chaque actionnaire peut \u00E9galement voter au moyen d\u0027une lettre ou de mani\u00E8re \u00E9lectronique par l\u0027interm\u00E9diaire d\u0027un formulaire \u00E9tabli par l\u0027organe d\u0027administration, qui contient les mentions suivantes : (i) l\u0027identification de l\u0027actionnaire, (ii) le nombre de voix auquel il a droit et (iii) pour chaque d\u00E9cision qui doit \u00EAtre prise par l\u0027assembl\u00E9e conform\u00E9ment \u00E0 ",
      "change_kind": "restated",
      "article_title": "DROIT DE VO\u0422\u0415",
      "article_number": "21"
    },
    {
      "summary": "L\u0027exercice social commence le premier avril de chaque ann\u00E9e pour se terminer le trente-et-un mars de l\u0027ann\u00E9e suivante.",
      "new_text": "L\u0027exercice social commence le premier avril de chaque ann\u00E9e pour se terminer le trente-et-un mars de l\u0027ann\u00E9e suivante.",
      "change_kind": "restated",
      "article_title": "EXERCICE SOCIAL- COMPTES ANNUELS - RAPPORT ANNUEL",
      "article_number": "24"
    },
    {
      "summary": "Si et aussi longtemps que la loi l\u0027exige, il est effectu\u00E9 annuellement sur les b\u00E9n\u00E9fices nets de la soci\u00E9t\u00E9 un pr\u00E9l\u00E8vement de cinq pour cent au moins qui est affect\u00E9 \u00E0 la constitution de la r\u00E9serve l\u00E9gale.",
      "new_text": "Si et aussi longtemps que la loi l\u0027exige, il est effectu\u00E9 annuellement sur les b\u00E9n\u00E9fices nets de la soci\u00E9t\u00E9 un pr\u00E9l\u00E8vement de cinq pour cent au moins qui est affect\u00E9 \u00E0 la constitution de la r\u00E9serve l\u00E9gale. Sur proposition de l\u0027organe d\u0027administration, l\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de l\u0027affectation \u00E0 donner au solde des b\u00E9n\u00E9fices nets.",
      "change_kind": "restated",
      "article_title": "R\u00C9PARTITION DES B\u00C9N\u00C9FICES",
      "article_number": "25"
    },
    {
      "summary": "La soci\u00E9t\u00E9 peut en tout temps \u00EAtre dissoute par d\u00E9cision de l\u0027assembl\u00E9e g\u00E9n\u00E9rale qui d\u00E9lib\u00E8re de la mani\u00E8re requise par la loi, ou est dissoute dans les cas pr\u00E9vus par la loi. Lors de la dissolution avec liquidation, un ou plusieurs liquidateurs sont nomm\u00E9s le cas \u00E9ch\u00E9ant par l\u0027assembl\u00E9e g\u00E9n\u00E9rale.",
      "new_text": "La soci\u00E9t\u00E9 peut en tout temps \u00EAtre dissoute par d\u00E9cision de l\u0027assembl\u00E9e g\u00E9n\u00E9rale qui d\u00E9lib\u00E8re de la mani\u00E8re requise par la loi, ou est dissoute dans les cas pr\u00E9vus par la loi. Lors de la dissolution avec liquidation, un ou plusieurs liquidateurs sont nomm\u00E9s le cas \u00E9ch\u00E9ant par l\u0027assembl\u00E9e g\u00E9n\u00E9rale",
      "change_kind": "restated",
      "article_title": "DISSOLUTION ET LIQUIDATION",
      "article_number": "27"
    }
  ],
  "governance_change": {
    "organ_kind_after": "collegial",
    "organ_kind_before": "collegial",
    "admin_delegated_added": [],
    "representation_rule_after": "twee_gezamenlijk",
    "co_signature_threshold_eur": null,
    "representation_rule_before": null
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Tim CARNEWAL",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "le rapport de l\u0027organe d\u0027administration \u00E9tabli conform\u00E9ment \u00E0 l\u0027article 7:155 du Code des soci\u00E9t\u00E9s et des associations",
    "le texte coordonn\u00E9 des statuts"
  ],
  "shareholder_rights": {
    "quorum_rules_changed": false,
    "liquidation_preference_text": "Les actionnaires r\u00E9partissent le solde de liquidation dans le respect du principe d\u0027\u00E9galit\u00E9.",
    "voorkeurrecht_rules_changed": false,
    "aandelenoverdracht_restrictions_changed": true
  },
  "voorwerp_change_summary": "L\u0027objet de la soci\u00E9t\u00E9 a \u00E9t\u00E9 \u00E9tendu pour inclure une gamme plus large d\u0027activit\u00E9s, notamment le commerce de produits pharmaceutiques, la gestion de biens immobiliers, la production et la commercialisation de technologies informatiques, le transport et la logistique, ainsi que les services de conseil et de commerce \u00E9lectronique.",
  "capital_structure_change": {
    "operations": [
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": 67500,
    "shares_before": null,
    "capital_after_eur": 86745274.0,
    "capital_before_eur": null,
    "share_classes_after": [
      {
        "count": 67500,
        "label": "actions",
        "rights_summary": "Toutes les actions conf\u00E8rent d\u00E9sormais les m\u00EAmes droits.",
        "voting_per_share": 1.0
      }
    ]
  },
  "coordinated_text_lineage": null
}

{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "Newpharma Group"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": true,
    "effective_date": "2025-10-31",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  },
  "signature_regime": "joint_two",
  "special_mandates": [
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Monsieur Lowie Dekrem, Madame Juna Jacquemin, Monsieur Bart Vander Elst et tout autre collaborateur de la soci\u00E9t\u00E9 anonyme \u003C Colruyt Group \u00BB, tous ayant \u00E9lu domicile \u00E0 cet effet \u00E0 1500 Hal, Edingensesteenweg 196, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u0027\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer l\u0027inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "Lowie Dekrem",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    },
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Monsieur Lowie Dekrem, Madame Juna Jacquemin, Monsieur Bart Vander Elst et tout autre collaborateur de la soci\u00E9t\u00E9 anonyme \u003C Colruyt Group \u00BB, tous ayant \u00E9lu domicile \u00E0 cet effet \u00E0 1500 Hal, Edingensesteenweg 196, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u0027\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer l\u0027inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "Juna Jacquemin",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    },
    {
      "quote": "L\u0027assembl\u00E9e conf\u00E8re tous pouvoirs \u00E0 Monsieur Lowie Dekrem, Madame Juna Jacquemin, Monsieur Bart Vander Elst et tout autre collaborateur de la soci\u00E9t\u00E9 anonyme \u003C Colruyt Group \u00BB, tous ayant \u00E9lu domicile \u00E0 cet effet \u00E0 1500 Hal, Edingensesteenweg 196, chacun agissant s\u00E9par\u00E9ment, ainsi qu\u0027\u00E0 leurs employ\u00E9s, pr\u00E9pos\u00E9s et mandataires, avec droit de substitution, afin d\u0027assurer les formalit\u00E9s aupr\u00E8s d\u0027un guichet d\u0027entreprise en vue d\u0027assurer l\u0027inscription/la modification des donn\u00E9es dans la Banque Carrefour des Entreprises et, le cas \u00E9ch\u00E9ant, aupr\u00E8s de l\u0027Administration de la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "Bart Vander Elst",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 86745274.0,
      "currency": "EUR",
      "after_eur": 86745274.0,
      "delta_eur": 86745274.0,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-10-31",
      "evidence_quote": "Article 5. CAPITAL. Le capital est fix\u00E9 \u00E0 quatre-vingt-six millions sept cent quarante-cinq mille deux cent septante-quatre euros (\u20AC 86.745.274,00).",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "stage": "completed",
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-11-20",
    "filing_date": "2025-11-12",
    "act_kind_objet": "OP\u00C9RATION ASSIMIL\u00C9E \u00C0 LA FUSION PAR ABSORPTION DE \u003C\u003C\u003C"
  },
  "decision": {
    "body": "bijzondere_algemene_vergadering",
    "act_date": "2025-10-28",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0684.465.652",
        "name": "Newpharma Group",
        "role": "acquiring",
        "address": "4020 Li\u00E8ge, Rue du Charbonnage 10 bo\u00EEte 2",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0821.903.467",
        "name": "Smartvalue",
        "role": "absorbed",
        "address": "4020 Li\u00E8ge, Rue du Charbonnage 10 bo\u00EEte B2",
        "is_foreign": false,
        "legal_form": "Soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50",
      "12:75"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2025-04-01",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le patrimoine entier de la soci\u00E9t\u00E9 absorb\u00E9e est transf\u00E9r\u00E9 \u00E0 titre universel \u00E0 la soci\u00E9t\u00E9 absorbante, sans exception ni r\u00E9serve.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2025-04-01"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "Newpharma Group",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Tim CARNEWAL",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de Newpharma Group, r\u00E9unie le 28 octobre 2025, a approuv\u00E9 une op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption, par laquelle Newpharma Group absorbe Smartvalue. Le patrimoine entier de Smartvalue est transf\u00E9r\u00E9 \u00E0 titre universel \u00E0 Newpharma Group \u00E0 compter du 1er avril 2025. L\u0027assembl\u00E9e a \u00E9galement adopt\u00E9 un nouveau texte des statuts, supprim\u00E9 les classes d\u0027actions et annul\u00E9 les droits de souscription de parts b\u00E9n\u00E9ficiaires.",
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "le rapport de l\u0027organe d\u0027administration \u00E9tabli conform\u00E9ment \u00E0 l\u0027article 7:155 du Code des soci\u00E9t\u00E9s et des associations",
    "le texte coordonn\u00E9 des statuts"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": true
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "Newpharma Group"
  },
  "legal_form_change": {
    "new": "",
    "old": "",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "fusion_share_issue",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": "2025-11-20",
    "filing_date": "2025-11-12",
    "act_kind_objet": "Objet de l\u0027acte :"
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2025-10-28",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "Newpharma Group",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": null,
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition",
    "plan financier",
    "bankattest",
    "verslag bedrijfsrevisor"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-11-20",
    "filing_date": "2025-11-12",
    "act_kind_objet": "OP\u00C9RATION ASSIMIL\u00C9E \u00C0 LA FUSION PAR ABSORPTION DE \u003C\u003C\u003C SMARTVALUE \u00BB SA - PROC\u00C8S-VERBAL DE L\u0027ASSEMBL\u00C9E G\u00C9N\u00C9RALE EXTRAORDINAIRE DE LA SOCI\u00C9T\u00C9 ABSORBANTE - SUPPRESSION DES CLASSES D\u0027ACTIONS ET ANNULATION DES DROITS DE SOUSCRIPTION DE PARTS B\u00C9N\u00C9FICIAIRES - ADOPTION D\u0027UN NOUVEAU TEXTE DES STATUTS"
  },
  "key_dates": [
    {
      "date": "2025-10-28",
      "label": "Act date"
    },
    {
      "date": "2025-04-01",
      "label": "Date comptable"
    },
    {
      "date": "2025-10-31",
      "label": "Date juridique"
    },
    {
      "date": "2017-12-18",
      "label": "Date of previous resolution"
    },
    {
      "date": "2018-01-15",
      "label": "Date of publication of previous resolution"
    }
  ],
  "key_parties": [
    {
      "kbo": "0684.465.652",
      "kind": "org",
      "name": "Newpharma Group",
      "role": "Soci\u00E9t\u00E9 Absorbante"
    },
    {
      "kind": "person",
      "name": "Lowie Dekrem",
      "role": "Volmachtnemer"
    },
    {
      "kind": "person",
      "name": "Juna Jacquemin",
      "role": "Volmachtnemer"
    },
    {
      "kind": "person",
      "name": "Bart Vander Elst",
      "role": "Volmachtnemer"
    },
    {
      "kind": "org",
      "name": "Colruyt Group",
      "role": "Volmachtnemer"
    },
    {
      "kind": "person",
      "name": "Eric Spruyt",
      "role": "Notaris"
    },
    {
      "kind": "person",
      "name": "Tim CARNEWAL",
      "role": "Notaire instrumentaire"
    },
    {
      "kind": "org",
      "name": "Berquin Notaires",
      "role": "\u00C9tude notariale"
    }
  ],
  "key_amounts_eur": [
    {
      "label": "Capital",
      "amount": 86745274.0
    }
  ],
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "Newpharma Group",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": null
  },
  "summary_narrative": "",
  "co_filed_documents": [],
  "detected_real_type": "fusion_proposal"
}

{
  "stage": "proposal",
  "notary": {
    "name": "T\u00E9o Lizin",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-09-04",
    "filing_date": "2025-08-26",
    "act_kind_objet": "D\u00C9P\u00D4T D\u0027UN PROJET DE FUSION \u00C9TABLIE CONFORM\u00C9MENT AUX"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-08-20",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0821.903.467",
        "name": "SA Smartvalue",
        "role": "absorbed",
        "address": "Rue du Charbonnage 10 bo\u00EEte B2, 4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0684.465.652",
        "name": "NEWPHARMA GROUP",
        "role": "acquiring",
        "address": "Rue du Charbonnage 10 bo\u00EEte 2, 4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50",
      "12:51",
      "12:53",
      "12:58"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": "2025-04-01",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "L\u0027ensemble du patrimoine, tant les droits que les obligations, de la soci\u00E9t\u00E9 absorb\u00E9e (Smartvalue SA) sera transf\u00E9r\u00E9 \u00E0 la soci\u00E9t\u00E9 absorbante (Newpharma Group SA), y compris les activit\u00E9s informatiques, logistiques, marketing, service client et infrastructure du groupe. Aucun bien immobilier n\u0027est inclus dans le transfert.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2025-04-01"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0474.073.840",
    "org_name": "Liedekerke Wolters Waelbroeck Kirkpatrick BV",
    "person_name": null,
    "org_rep_person_name": "T\u00E9o Lizin"
  },
  "summary_narrative": "Le projet de fusion silencieuse entre Smartvalue SA et Newpharma Group SA, soumis \u00E0 l\u0027approbation des assembl\u00E9es g\u00E9n\u00E9rales extraordinaires, pr\u00E9voit la dissolution sans liquidation de Smartvalue SA et le transfert int\u00E9gral de son patrimoine \u00E0 Newpharma Group SA, conform\u00E9ment aux articles 12:7 et 12:50 \u00E0 12:58 du Code des soci\u00E9t\u00E9s et associations. La fusion, qui sera effective \u00E0 compter du 31 octobre 2025, vise \u00E0 rationaliser la structure du groupe et \u00E0 renforcer l\u0027efficacit\u00E9 op\u00E9rationnelle. Les op\u00E9rations comptables seront r\u00E9troactives \u00E0 partir du 1er avril 2025.",
  "co_filed_documents": [
    "projet de fusion dans le cadre d\u0027une op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption conform\u00E9ment aux articles 12:7, 12:50 et suivants du Code des soci\u00E9t\u00E9s et associations de Newpharma Group SA du 20 ao\u00FBt 2025."
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "stage": "proposal",
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-09-04",
    "filing_date": "2025-08-26",
    "act_kind_objet": "D\u00C9P\u00D4T D\u0027UN PROJET DE FUSION \u00C9TABLIE CONFORM\u00C9MENT AUX"
  },
  "decision": {
    "body": null,
    "act_date": "2025-08-20",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": {
    "summary": "L\u0027actionnaire unique renonce \u00E0 ce qu\u0027est pr\u00E9vu \u00E0 l\u0027article 12 :51, \u00A72, 4\u00B0 du CSA.",
    "articles": [
      "12:51 \u00A72 4\u00B0"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": "0821.903.467",
        "name": "SA Smartvalue",
        "role": "absorbed",
        "address": "Rue du Charbonnage 10 bo\u00EEte B2 \u00E0 4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0684.465.652",
        "name": "SA NEWPHARMA GROUP",
        "role": "acquiring",
        "address": "Rue du Charbonnage 10 bo\u00EEte 2 \u00E0 4020 Li\u00E8ge",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:7",
      "12:50",
      "12:58",
      "12:2"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "L\u0027ensemble du patrimoine, tant les droits que les obligations, \u00E0 l\u0027exception de tout le patrimoine, de la Soci\u00E9t\u00E9 \u00E0 Absorber sera transmis \u00E0 la Soci\u00E9t\u00E9 Absorbante.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2025-04-01"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "Liedekerke Wolters Waelbroeck Kirkpatrick BV",
    "person_name": null,
    "org_rep_person_name": null
  },
  "summary_narrative": "Le conseil d\u0027administration de la SA Smartvalue et de la SA Newpharma Group a d\u00E9cid\u00E9 de pr\u00E9senter un projet de fusion conforme aux articles 12:7 et 12:50 \u00E0 12:58 du Code des soci\u00E9t\u00E9s et associations. Il s\u0027agit d\u0027une fusion silencieuse par absorption, dont le projet sera soumis \u00E0 l\u0027approbation des assembl\u00E9es g\u00E9n\u00E9rales extraordinaires des deux soci\u00E9t\u00E9s.",
  "co_filed_documents": [
    "projet de fusion dans le cadre d\u0027une op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption conform\u00E9ment aux articles 12:7, 12:50 et suivants du Code des soci\u00E9t\u00E9s et associations de Newpharma Group SA du 20 ao\u00FBt 2025"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 94500000,
      "delta_eur": 7000000,
      "before_eur": 87500000,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 94500000.0,
      "delta_eur": 7000000.0,
      "before_eur": 87500000.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "numeraire",
      "paid_up_delta_eur": 7000000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_decrease",
      "after_eur": 86745274.0,
      "delta_eur": -7754726.0,
      "before_eur": 94500000.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": "loss_absorption",
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTAIRES",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-04-04",
    "filing_date": "2025-04-02",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2025-03-21",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "procuration",
    "texte coordonn\u00E9 des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 7000000.0,
      "currency": "EUR",
      "after_eur": 94500000.0,
      "delta_eur": 7000000.0,
      "before_eur": 87500000.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-03-21",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 par apport en num\u00E9raire \u00E0 concurrence de 7.000.000,00 EUR, pour le porter de 87.500.000,00 EUR \u00E0 94.500.000,00 EUR",
      "contribution_type": "cash"
    },
    {
      "kind": "capital_decrease",
      "amount": 7754726.0,
      "currency": "EUR",
      "after_eur": 86745274.0,
      "delta_eur": -7754726.0,
      "before_eur": 94500000.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-03-21",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital par apurement des pertes subies, conform\u00E9ment \u00E0 l\u0027article 7:210 du Code des soci\u00E9t\u00E9s et des associations, \u00E0 concurrence de 7.754.726 EUR, pour le ramener de 94.500.000,00 EUR \u00E0 86.745.274,00 EUR",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2025-03-21",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "BERQUIN NOTAIRES",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2025-04-04",
    "filing_date": "2025-04-02",
    "act_kind_objet": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS)"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-03-21",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "full_restatement",
      "targeted_amendment",
      "legal_form_change",
      "wvv_adaptation",
      "name_change",
      "object_change",
      "duration_change",
      "share_split",
      "share_consolidation",
      "share_class_creation",
      "language_switch",
      "warrant_exercise_capital_update",
      "board_authorized_capital",
      "governance_restructure",
      "liquidation_preference_introduction",
      "seat_region_change",
      "other"
    ],
    "scope": "full_restatement",
    "trigger": "wvv_adaptation",
    "language_after": "fr",
    "language_before": "fr"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full_after": "NEWPHARMA GROUP",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "NEWPHARMA GROUP",
    "current_zetel_raw": "Rue du Charbonnage 10 bte 2 : 4020 Li\u00E8ge",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [],
  "articles_modified": [
    {
      "summary": "Remplacement du premier alin\u00E9a de l\u0027article 5 des statuts pour fixer le capital \u00E0 94.500.000,00 EUR.",
      "new_text": "Le capital est fix\u00E9 \u00E0 nonante-quatre millions cinq cent mille euros (\u20AC 94.500.000,00).",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5"
    },
    {
      "summary": "Remplacement du premier alin\u00E9a de l\u0027article 5 des statuts pour fixer le capital \u00E0 86.745.274,00 EUR.",
      "new_text": "Le capital est fix\u00E9 \u00E0 quatre-vingt-six millions sept cent quarante-cinq mille deux cent septante-quatre euros (\u20AC 86.745.274,00).",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "5"
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Tim CARNEWAL",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "une procuration",
    "le texte coordonn\u00E9 des statuts"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": null,
  "capital_structure_change": {
    "operations": [
      "capital_increase_cash",
      "capital_decrease",
      "share_class_creation"
    ],
    "split_ratio": null,
    "shares_after": null,
    "shares_before": null,
    "capital_after_eur": 86745274.0,
    "capital_before_eur": 87500000.0,
    "share_classes_after": []
  },
  "coordinated_text_lineage": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "notary": {
    "name": "Hendrik Muyshondt",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Halle",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-06-14",
    "filing_date": "2024-06-12",
    "act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), ANNEE COMPTABLE, ASSEMBLEE GENERALE"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2023-12-14",
    "unanimous": null
  },
  "statute_change": {
    "kinds": [
      "translation",
      "coordination",
      "targeted_amendment",
      "duration_change"
    ],
    "scope": "translation_only",
    "trigger": "wvv_adaptation",
    "language_after": "nl",
    "language_before": "nl"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full_after": "NEWPHARMA GROUP",
    "legal_form_after": "Soci\u00E9t\u00E9 anonyme",
    "name_full_before": "NEWPHARMA GROUP",
    "current_zetel_raw": "Rue du Charbonnage 10 bte 2 : 4020 Li\u00E8ge",
    "legal_form_before": "Soci\u00E9t\u00E9 anonyme"
  },
  "special_mandates": [
    {
      "holder_kbo": null,
      "holder_name": "SA COLRUYT GROUP",
      "scope_categories": [
        "kbo",
        "ub",
        "btw"
      ],
      "with_substitution": true
    }
  ],
  "articles_modified": [
    {
      "summary": "De eerste zin van artikel 30 is gewijzigd om de start- en einddatum van het sociale jaar te specificeren.",
      "new_text": "L\u0027exercice social commence le premier avril et se termine le trente-et-un mars de l\u0027ann\u00E9e suivante.",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "30"
    },
    {
      "summary": "De eerste zin van het eerste paragraaf van artikel 18 is gewijzigd om de datum en tijd van de algemene vergadering te specificeren.",
      "new_text": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires se r\u00E9unit le troisi\u00E8me mardi du mois septembre \u00E0 14.30 heures.",
      "change_kind": "amended",
      "article_title": null,
      "article_number": "18"
    }
  ],
  "governance_change": null,
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Hendrik Muyshondt",
    "org_rep_person_name": null
  },
  "co_filed_documents": [
    "exp\u00E9dition de l\u0027acte de modification des statuts avec mandat et statuts co\u00F6rdonn\u00E9s"
  ],
  "shareholder_rights": null,
  "voorwerp_change_summary": "De voorwerp van de statuten is gewijzigd met een vertaling, co\u00F6rdinatie en andere wijzigingen, inclusief de jaarrekening en de algemene vergadering.",
  "capital_structure_change": null,
  "coordinated_text_lineage": null
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-12-14",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [
    {
      "quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de donner la mission \u00E0 Ma\u00EEtre Willem MUYSHONDT et Ma\u00EEtre Hendrik MUYSHONDT, notaires associ\u00E9s \u00E0 Halle d\u2019\u00E9tablir et de signer la coordination des statuts, conform\u00E9ment \u00E0 la d\u00E9cision pr\u00E9c\u00E9dente, et d\u2019assurer son d\u00E9p\u00F4t au dossier de la soci\u00E9t\u00E9.",
      "holder_kbo": null,
      "holder_name": "Ma\u00EEtre Willem MUYSHONDT et Ma\u00EEtre Hendrik MUYSHONDT",
      "scope_categories": [
        "coordination",
        "depot"
      ],
      "with_substitution": false
    },
    {
      "quote": "La soci\u00E9t\u00E9 constitue pour son mandataire sp\u00E9cial, avec facult\u00E9 de substitution, le personnel de la SA COLRUYT GROUP, \u00E0 qui elle conf\u00E8re tous pouvoirs aux fins d\u0027accomplir les formalit\u00E9s n\u00E9cessaires \u00E0 l\u0027immatriculation de la soci\u00E9t\u00E9 \u00E0 la Banque-carrefour des entreprises, au guichet d\u0027entreprise et \u00E0 la Taxe sur la Valeur Ajout\u00E9e.",
      "holder_kbo": null,
      "holder_name": "le personnel de la SA COLRUYT GROUP",
      "scope_categories": [
        "KBO",
        "tax",
        "filing"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Emilie Van Callemont",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "SRL EY R\u00E9viseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme en tant que commissaire aux comptes la SRL EY R\u00E9viseurs d\u0027Entreprises, dont le si\u00E8ge social est situ\u00E9 \u00E0 4000 Li\u00E8ge, rue des Guillemins 129, bo\u00EEte 3, repr\u00E9sent\u00E9e par Madame Emilie Van Callemont, pour une dur\u00E9e de trois ans."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "EY R\u00E9viseurs d\u0027Entreprises",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP SA"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 87500000.0,
      "delta_eur": 20000000.0,
      "before_eur": 67500000.0,
      "contribution_type": "geld"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2023-03-28",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  },
  "signature_regime": null,
  "special_mandates": [],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 20000000.0,
      "currency": "EUR",
      "after_eur": 87500000.0,
      "delta_eur": 20000000.0,
      "before_eur": 67500000.0,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-03-28",
      "evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital de la Soci\u00E9t\u00E9 en num\u00E9raire \u00E0 concurrence de 20.000.000,00 EUR, pour le porter de 67.500.000,00 EUR \u00E0 87.500.000,00 EUR",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": false
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 87500000.0,
      "delta_eur": 20000000.0,
      "before_eur": 67500000.0,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 20000000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tim CARNEWAL",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2023-04-07",
    "filing_date": "2023-04-05",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decision": {
    "body": "assembl\u00E9e_generale_extraordinaire",
    "act_date": "2023-03-28",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "Soci\u00E9t\u00E9 anonyme",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "exp\u00E9dition du proc\u00E8s-verbal",
    "procuration",
    "texte coordonn\u00E9 des statuts"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Etablissements Franz Colruyt SA",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Etablissements Franz Colruyt SA",
        "address": null,
        "country": "BE",
        "legal_form": "SA"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 1) Etablissements Franz Colruyt SA, repr\u00E9sent\u00E9e par M. Stefaan Vandamme;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Korys Business Services I SA",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Korys Business Services I SA",
        "address": null,
        "country": "BE",
        "legal_form": "SA"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 2) Korys Business Services I SA, repr\u00E9\u0161sent\u00E9e par M. Dries Colpaert;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Korys Business Services II SA",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": {
        "kbo": null,
        "name": "Korys Business Services II SA",
        "address": null,
        "country": "BE",
        "legal_form": "SA"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 3) Korys Business Services II SA, repr\u00E9sent\u00E9e par M. Dries Crevits;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Lisa Colruyt",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 4) Mme. Lisa Colruyt;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Organisation - Management - Consultancy and Relations SRL",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "rechtzetting",
      "subkind": "rectification",
      "via_org": {
        "kbo": null,
        "name": "Organisation - Management - Consultancy and Relations SRL",
        "address": null,
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2021-12-31",
      "evidence_quote": "CONFIRME, pour le bon ordre des choses, la d\u00E9mission des administrateurs suivants, avec effet au 31 d\u00E9cembre 2021, qu\u00ED ava\u00EDt \u00E9t\u00E9 act\u00E9e par \u013E\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la Soc\u00ED\u00E9t\u00E9 du 25 ao\u00FBt 2021",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_date",
        "value": "2021-12-31"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "retroactive"
    },
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "JGO SRL",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "rechtzetting",
      "subkind": "rectification",
      "via_org": {
        "kbo": null,
        "name": "JGO SRL",
        "address": null,
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2021-12-31",
      "evidence_quote": "CONFIRME, pour le bon ordre des choses, la d\u00E9mission des administrateurs suivants, avec effet au 31 d\u00E9cembre 2021, qu\u00ED ava\u00EDt \u00E9t\u00E9 act\u00E9e par \u013E\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la Soc\u00ED\u00E9t\u00E9 du 25 ao\u00FBt 2021",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_date",
        "value": "2021-12-31"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "retroactive"
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Jef Colruyt",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes et ce pour une dur\u00E9e de six ann\u00E9es, se terminant ainsi \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de la Soci\u00E9t\u00E9 qui se tiendra en 2029",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Stefaan Vandamme",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes et ce pour une dur\u00E9e de six ann\u00E9es, se terminant ainsi \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de la Soci\u00E9t\u00E9 qui se tiendra en 2029",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Jo Willemyns",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes et ce pour une dur\u00E9e de six ann\u00E9es, se terminant ainsi \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de la Soci\u00E9t\u00E9 qui se tiendra en 2029",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Stefan Goethaert",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes et ce pour une dur\u00E9e de six ann\u00E9es, se terminant ainsi \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de la Soci\u00E9t\u00E9 qui se tiendra en 2029",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Kris Castelein",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": null,
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes et ce pour une dur\u00E9e de six ann\u00E9es, se terminant ainsi \u00E0 l\u0027issue de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire de la Soci\u00E9t\u00E9 qui se tiendra en 2029",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur-d\u00E9l\u00E9gu\u00E9",
      "person": {
        "rrn": null,
        "name": "Gilles Jourquin",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "confirmation",
      "via_org": {
        "kbo": null,
        "name": "GJ Lifesciences Management SRL",
        "address": null,
        "country": "BE",
        "legal_form": "SRL"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "CONFIRM\u00C9, pour le bon ordre des choses, le mandat d\u0027administrateur(-d\u00E9l\u00E9gu\u00E9) GJ Lifesciences Management SRL, repr\u00E9sent\u00E9e par M. Gilles Jourquin, qui avait \u00E9t\u00E9 nomm\u00E9e en tant qu\u0027administrateur-d\u00E9l\u00E9gu\u00E9 par d\u00E9cision de l\u0027assembl\u00E9e g\u00E9n\u00E9rale du 14 juillet 2021",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2027"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "future"
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Etablissements Franz Colruyt SA",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Les pouvoirs accord\u00E9s \u00E0 ces administrateurs en leur qualit\u00E9 d\u0027administrateur sont r\u00E9voqu\u00E9s av\u00E9c effet en date des pr\u00E9sentes.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Korys Business Services I SA",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Les pouvoirs accord\u00E9s \u00E0 ces administrateurs en leur qualit\u00E9 d\u0027administrateur sont r\u00E9voqu\u00E9s av\u00E9c effet en date des pr\u00E9sentes.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Korys Business Services II SA",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Les pouvoirs accord\u00E9s \u00E0 ces administrateurs en leur qualit\u00E9 d\u0027administrateur sont r\u00E9voqu\u00E9s av\u00E9c effet en date des pr\u00E9sentes.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Lisa Colruyt",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Les pouvoirs accord\u00E9s \u00E0 ces administrateurs en leur qualit\u00E9 d\u0027administrateur sont r\u00E9voqu\u00E9s av\u00E9c effet en date des pr\u00E9sentes.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Organisation - Management - Consultancy and Relations SRL",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2021-12-31",
      "evidence_quote": "L\u0027Actionnaire Unique confirme avoir d\u00FBment inform\u00E9 les administrateurs d\u00E9missionnaires de leur d\u00E9mission conform\u00E9ment \u00E0 l\u0027article 7:133 du Code des Soci\u00E9t\u00E9s et des Associations.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "retroactive"
    },
    {
      "kind": "decharge_granted",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "JGO SRL",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2021-12-31",
      "evidence_quote": "L\u0027Actionnaire Unique confirme avoir d\u00FBment inform\u00E9 les administrateurs d\u00E9missionnaires de leur d\u00E9mission conform\u00E9ment \u00E0 l\u0027article 7:133 du Code des Soci\u00E9t\u00E9s et des Associations.",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "retroactive"
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": null,
    "filing_date": "2023-03-13",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "buitengewone_algemene_vergadering",
      "date": "2023-01-20",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NewPharma Group",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Mathias AERTSEN",
    "org_rep_person_name": null,
    "person_role_at_subject": "mandataire"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Etablissements Franz Colruyt SA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Korys Business Services I SA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Korys Business Services II SA",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Mme. Lisa Colruyt",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Organisation - Management - Consultancy and Relations SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_out",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "JGO SRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "M. Jef Colruyt",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "M. Stefaan Vandamme",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "M. Jo Willemyns",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "M. Stefan Goethaert",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "M. Kris Castelein",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator-delegated",
      "person": {
        "rrn": null,
        "name": "GJ Lifesciences Management SRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NewPharma Group"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Stefaan Vandamme",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "Etablissements Franz Colruyt SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 1) Etablissements Franz Colruyt SA, repr\u00E9sent\u00E9e par M. Stefaan Vandamme;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dries Colpaert",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "Korys Business Services I SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 2) Korys Business Services I SA, repr\u00E9sent\u00E9e par M. Dries Colpaert;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dries Crevits",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "Korys Business Services II SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 3) Korys Business Services II SA, repr\u00E9sent\u00E9e par M. Dries Crevits;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Lisa Colruyt",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "PRIS ACTE de la d\u00E9mission des administrateurs suivants de la Soci\u00E9t\u00E9, avec effet en date des pr\u00E9sentes: 4) Mme. Lisa Colruyt;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Olivier Witmeur",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "Organisation - Management - Consultancy and Relations SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-12-31",
      "evidence_quote": "CONFIRME, pour le bon ordre des choses, la d\u00E9mission des administrateurs suivants, avec effet au 31 d\u00E9cembre 2021... a. Organisation - Management - Consultancy and Relations SRL, repr\u00E9sent\u00E9e par M. Olivier Witmeur;"
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "J\u00E9r\u00F4me Gobesso",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "JGO SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-12-31",
      "evidence_quote": "CONFIRME, pour le bon ordre des choses, la d\u00E9mission des administrateurs suivants, avec effet au 31 d\u00E9cembre 2021... b. JGO SRL, repr\u00E9sent\u00E9e par M. J\u00E9r\u00F4me Gobesso."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jef Colruyt",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes... 1) M. Jef Colruyt;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Stefaan Vandamme",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes... 2) M. Stefaan Vandamme;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jo Willemyns",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes... 3) M. Jo Willemyns;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Stefan Goethaert",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes... 4) M. Stefan Goethaert;"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Kris Castelein",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "D\u00C9CID\u00C9 de nommer les personnes suivantes au mandat d\u0027administrateur, avec effet imm\u00E9diat en date des pr\u00E9sentes... 5) M. Kris Castelein."
    },
    {
      "kind": "director_renew",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Gilles Jourquin",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0684465652",
        "name": "GJ Lifesciences Management SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2023-03-13",
      "evidence_quote": "CONFIRM\u00C9, pour le bon ordre des choses, le mandat d\u0027administrateur(-d\u00E9l\u00E9gu\u00E9) GJ Lifesciences Management SRL, repr\u00E9sent\u00E9e par M. Gilles Jourquin, qui avait \u00E9t\u00E9 nomm\u00E9e en tant qu\u0027administrateur-d\u00E9l\u00E9gu\u00E9 par d\u00E9cision de l\u0027assembl\u00E9e g\u00E9n\u00E9rale du 14 juillet 2021."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Thomas de Kempeneer",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0885971571",
        "name": "Korys Management SA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2022-04-01",
      "evidence_quote": "La d\u00E9mission avec effet au 1 avril 2022 de la soci\u00E9t\u00E9 Korys Management SA, laquelle dispose du num\u00E9ro d\u0027entreprise 0885 971 571 et a son si\u00E8ge \u00E0 1500 Halle, Villalaan 96, ici repr\u00E9sent\u00E9e par son administrateur et repr\u00E9sentant permanent, Monsieur Thomas de Kempeneer, en tant qu\u0027administrateur de la S"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0684.465.652",
    "name_full": "NEWPHARMA GROUP",
    "legal_form": "SA"
  }
}